No Detail Found!

Incidence of Heparin Resistance after Preoperative Heparin Therapy in patients undergoing Open Heart Surgery

Author(s)
ALI NAEEM Abdullah Welfare Hospital, Nowshera Virkan.Pakistan
ATTAULLAH KHAN NIAZI Department of Cardiac Surgery, Shalamar Medical & Dental College, Lahore, Pakistan
MUHAMMAD MUNEEB Department of Cardiac Surgery, Shalamar Medical & Dental College, Lahore, Pakistan
AMMAR HAMEED KHAN Department of Cardiac Surgery, Sialkot Medical College, Sialkot, Pakistan
KIRAN MAZHAR Department of Cardiac Surgery, Shalamar Medical & Dental College Lahore, Pakistan
KANZA SANA UMER Department of Clinical Psychology, Kingdom of Saudi Arabia
Abstract
Aim: Incidence of Heparin Resistance after preoperative heparin therapy in patients undergoing open heart surgery. Methods: The Prospective Observational study included 124 patients of different heart diseases undergoing open heart surgery, at cardiac surgery department of Punjab Institute of Cardiology; Lahore Pakistan was performed between 5th October 2013 to 16 March 2014. Both genders age 18-75 were included. All those patients who present with diseases other than heart diseases, age <18 and > 75 were excluded in the study. Data was analyzed using Statistical Package for Social Sciences (SPSS) version 16.0. P-value = 0.05 were considered significant. Results: Our results showed that out of 124 patients, 87(70.16%) were male while 37(29.84%) were females. Clinical characteristics i.e. (hypertension, diabetes mellitus, emergency bypass, smoking, alcohol intake, hyperlipidemias, obesity and family history) were insignificantly associated with heparin resistance. The clinical characteristics i.e. (baseline activated clotting time, albumin and cross clamp time) were significantly associated with the development of heparin resistance as (p-value <0.05 .015, .041 and .025 respectively). Conclusion: The results indicate that the incidence of heparin resistance after preoperative heparin therapy was 8.06%.
Publication Details
Page(s) 126-128
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
Resistance after Preoperative Heparin Therapy
References
. .cardiopulmonary bypass in cardiac surgery. The Journal of extra-corporeal technology. 2010 Mar;42, (1) : 9.
. .Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity. 1987 Dec, 262(36) : 17356-61.
Shirasaka Y,Sakane T,Yamashita S . .Effect of P‐glycoprotein expression levels on the concentration‐dependent permeability of drugs to the cell membrane. Journal of pharmaceutical sciences. 2008 Jan, 1(1) : 553-65.
Shore-Lesserson L,Baker RA,Ferraris VA,Greilich PE,Fitzgerald D,Roman P,Hammon JW . .The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: clinical practice guidelines-anticoagulation during cardiopulmonary bypass. 2018 Feb, 1(2) : 650-62.
. .. 2018 Mar, 25(03) : 340-4.
. .Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week. 2022 May, 79(19) : 1949-62.
Levy JH,Connors JM . .Heparin resistance-clinical perspectives and management strategies. 2021 Aug, 26(9) : 826-32.
Saadalla A,Leger R,Ashrani AA,Pruthi RK,Chen D,Padmanabhan A,Heikal N. . .Diagnostic Utility of High Dose Heparin Confirmation Step in Heparin Induced Thrombocytopenia ELISA Assay. Blood. 2021 Nov, 23 : 3228.
Tshikudi DM,Simandoux O,Kang D,Van Cott EM,Andrawes MN,Yelin D,Nadkarni SK . .Imaging the dynamics and microstructure of fibrin clot polymerization in cardiac surgical patients using spectrally encoded confocal microscopy. 2021 Aug, 1(8) : 968-78.
Boer C,Meesters MI,Veerhoek D,Vonk AB . .Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. 2018 May, 1(5) : 914-27.
McNair E,Marcoux JA,Bally C,Gamble J,Thomson D . .Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery. Perfusion, 31(3) : 189-99.
Bauer A,Hausmann H,Schaarschmidt J,Szlapka M,Scharpenberg M,Eberle T,Hasenkam JM .2019 .Is 300 seconds ACT safe and efficient during MiECC procedures?. The Thoracic and Cardiovascular Surgeon, 67(03) : 191-202.
Nakayama Y,Nakajima Y,Tanaka KA,Sessler DI,Maeda S,Iida J,Ogawa S,Mizobe T . .Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. 2015 Jan, 1(1) : 91-102.
Sniecinski RM,Levy JH . .Anticoagulation management associated with extracorporeal circulation. Best Practice & Research Clinical Anaesthesiology. 2015 Jun, 1(2) : 189-202.
Shore-Lesserson L,Baker RA,Ferraris VA,Greilich PE,Fitzgerald D,Roman P,Hammon JW . .The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: clinical practice guidelines-anticoagulation during cardiopulmonary bypass. 2018 Feb, 1(2) : 650-62.
Sniecinski RM,Levy JH . .Anticoagulation management associated with extracorporeal circulation. Best Practice & Research Clinical Anaesthesiology. 2015 Jun, 1(2) : 189-202.
Li Z,Qu T,Ding C,Ma C,Sun H,Li S,Liu X . .Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis. 2015 Feb, 1 : 88-100.
. .. 2019 Oct, 1 : 286-92.
Kawatsu S,Sasaki K,Sakatsume K,Takahara S,Hosoyama K,Masaki N,Suzuki Y,Hayatsu Y,Yoshioka I,Sakuma K,Adachi O . .Predictors of heparin resistance before cardiovascular operations in adults. 2018 May, 1(5) : 1316-21.
Timm FP,Houle TT,Grabitz SD,Lihn AL,Stokholm JB,EikermannHaerter K,Nozari A,Kurth T,Eikermann M. Migraine . .and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. bmj. 2017 Jan, 10 : 356.
0

Citations

0

Downloads

75

Views